A carregar...
Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
Hsa-miRNA-326 (miR-326) has recently been discovered having anticancer efficacy in different organs. However, the role of miR-326 on non-small cell lung cancer (NSCLC) is still ambiguous. In this study, we investigated the role of miR-326 on the development of NSCLC. The results indicated that miR-3...
Na minha lista:
Publicado no: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Impact Journals LLC
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884997/ https://ncbi.nlm.nih.gov/pubmed/26840018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7071 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|